** Shares of China's pharmaceutical products distributor
Sinopharm Group Co Ltd 1099.HK surge as much as 5.7% to
HK$23.10, their highest since Aug 7
** Stock marks biggest intraday pct gain since March 16
** The Shanghai-based co posts an 11.1% YoY growth in H1
profit to 4.10 bln yuan ($562.90 mln) with revenue up 15.1% YoY
to 300.95 bln yuan due to recovery of medical services demand
and deepening of medical reform amid relaxation of pandemic
control measures
** The Hang Seng Commerce & Industry Index .HSNC rises
1.9%, healthcare index .HSCIH jumps 3.1% and the Hang Seng
Index .HSI climbs 1.7%
** As of last close, stock up 10.1% this year
($1 = 7.2837 Chinese yuan)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))